UBS Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.21M | Buy |
|
|||||
|
2025
Q2 | $2.75M | Sell |
|
|||||
|
2025
Q1 | $4.73M | Buy |
|
|||||
|
2024
Q4 | $7.03M | Buy |
|
|||||
|
2024
Q3 | $2.04M | Buy |
|
|||||
|
2024
Q2 | $1.04M | Sell |
|
|||||
|
2024
Q1 | $1.23M | Sell |
|
|||||
|
2023
Q4 | $1.68M | Buy |
|
|||||
|
2023
Q3 | $411K | Sell |
|
|||||
|
2023
Q2 | $1.9M | Buy |
|
|||||
|
2023
Q1 | $1.53M | Buy |
|
|||||
|
2022
Q4 | $745K | Buy |
|
|||||
|
2022
Q3 | $325K | Buy |
|
|||||
|
2022
Q2 | $241K | Sell |
|
|||||
|
2022
Q1 | $632K | Sell |
|
|||||
|
2021
Q4 | $2.85M | Buy |
|
|||||
|
2021
Q3 | $3.99M | Buy |
|
|||||
|
2021
Q2 | $1.8M | Sell |
|
|||||
|
2021
Q1 | $3.62M | Sell |
|
|||||
|
2020
Q4 | $6.25M | Buy |
|
|||||
|
2020
Q3 | $2.91M | Sell |
|
|||||
|
2020
Q2 | $2.93M | Sell |
|
|||||
|
2020
Q1 | $3.34M | Sell |
|
|||||
|
2019
Q4 | $4.32M | Buy |
|
|||||
|
2019
Q3 | $1.71M | Buy |
|
|||||
|
2019
Q2 | $1.35M | Buy |
|
|||||
|
2019
Q1 | $717K | Sell |
|
|||||
|
2018
Q4 | $636K | Buy |
|
|||||
|
2018
Q3 | $587K | Buy |
|
|||||
|
2018
Q2 | $459K | Buy |
|
|||||
|
2018
Q1 | $220K | Sell |
|
|||||
|
2017
Q4 | $331K | Buy |
|
|||||
|
2017
Q3 | $389K | Buy |
|
|||||
|
2017
Q2 | $302K | Buy |
|
|||||
|
2017
Q1 | $167K | Sell |
|
|||||
|
2016
Q4 | $309K | Buy |
|
|||||
|
2016
Q3 | $113K | Buy |
|
|||||
|
2016
Q2 | $105K | Buy |
|
|||||
|
2016
Q1 | $81K | Hold |
|
|||||
|
2015
Q4 | $94K | Sell |
|
|||||
|
2015
Q3 | $83K | Buy |
|
|||||
|
2015
Q2 | $28K | Buy |
|
|||||
|
2015
Q1 | $19K | Buy |
|
|||||
|
2014
Q4 | $1K | Buy |
|